{"context":{"query":">>mesh>>pharmgkb_clinical","source_dataset":"mesh","target_dataset":"pharmgkb_clinical"},"stats":{"queried":1,"total":13,"mapped":1},"pagination":{"has_next":false},"schema":"id|variant|gene|type|level_of_evidence|chemicals|phenotypes","mappings":[{"input":"D006528","source":"D006528|Carcinoma, Hepatocellular","targets":["RS12613732_GALNT14_1|rs12613732|GALNT14|Efficacy|3|cisplatin;fluorouracil;mitoxantrone|Hepatocellular Carcinoma","RS1799983_NOS3_6|rs1799983|NOS3|Efficacy|3|sorafenib|Hepatocellular Carcinoma","RS1800629_TNF_7|rs1800629|TNF|Toxicity|3|sorafenib|Hand-foot syndrome;Hepatocellular Carcinoma","RS1870377_KDR_1|rs1870377|KDR|Efficacy|3|sorafenib|Hepatocellular Carcinoma","RS2010963_VEGFA_4|rs2010963|VEGFA|Efficacy|3|sorafenib|Hepatocellular Carcinoma","RS2070744_NOS3_6|rs2070744|NOS3|Efficacy|3|sorafenib|Hepatocellular Carcinoma","RS2071559_KDR_1|rs2071559|KDR|Efficacy|3|sorafenib|Hepatocellular Carcinoma;Renal Cell Carcinoma","RS2257212_SLC15A2_1|rs2257212|SLC15A2|Efficacy|3|sorafenib|Hepatocellular Carcinoma","RS3025040_VEGFA_1|rs3025040|VEGFA|Toxicity|3|sorafenib|Hand-foot syndrome;Hepatocellular Carcinoma","RS4604006_1|rs4604006||Efficacy|3|sorafenib|Hepatocellular Carcinoma","RS7574296_UGT1A9_1|rs7574296|UGT1A9|Toxicity|3|sorafenib|Hand-foot syndrome;Hepatocellular Carcinoma","RS9679162_GALNT14_3|rs9679162|GALNT14|Efficacy|3|cisplatin;fluorouracil;mitoxantrone|Hepatocellular Carcinoma;Liver cancer","UGT1A1*1__UGT1A1*28_UGT1A1_10|UGT1A1*1, UGT1A1*28|UGT1A1|Toxicity|3|sorafenib|Hepatocellular Carcinoma;Hyperbilirubinemia"]}]}